https://www.selleckchem.com/products/iwp-2.html
022) and thrombectomy (p = 0.049). IMH was correlated with MVO (R = 0.62, p less then 0.001), necrosis (R = 0.58, p less then 0.001) and LVEF (R = -0.21, p = 0.04). Patients with IMH presented higher incidence of MACE events, independently of LVEF (p = 0.022). T2* mapping is a novel imaging approach that proves useful to asses IMH in the setting of reperfused STEMI. T2* IMH extent was associated with anterior infarction and thrombectomy. T2* IMH was associated with higher incidence of MACE events regardless preserved or reduced LVEF.C
Like
Comment
Share
